New robot arm takes on cancer surgery – first safety check begins

NCT ID NCT07632638

Recruiting now Knowledge-focused Sponsor: Instituto do Cancer do Estado de São Paulo Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This study will test a new robotic surgery platform called RonovoTM in 40 adults with cancer who need elective surgery. The robot helps surgeons perform minimally invasive procedures in digestive, thoracic, urology, and gynecology areas. Researchers will track complications, technical failures, and how well the surgery goes to see if the platform is safe and effective.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: RonovoTM Robotic Surgical Platform
What this could lead to: If successful, this could provide safety data to support regulatory approval of a new robotic surgery tool for cancer operations in Latin America.
What could go wrong: This is a small, early-stage registry with only 40 participants and no comparison group, so results may not apply broadly. Technical failures or complications could occur.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER MALIGNANT NEOPLASMS

Contacts and locations

Locations

Instituto do Câncer do Estado de São Paulo - ICESP
RECRUITING

São Paulo, São Paulo, 05403-010, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.